A detailed history of Quest Partners LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 13,004 shares of CDNA stock, worth $288,038. This represents 0.04% of its overall portfolio holdings.

Number of Shares
13,004
Previous 5,611 131.76%
Holding current value
$288,038
Previous $175 Million 58.91%
% of portfolio
0.04%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$20.4 - $32.2 $150,817 - $238,054
7,393 Added 131.76%
13,004 $278 Million
Q3 2024

Nov 07, 2024

BUY
$14.41 - $33.99 $22,191 - $52,344
1,540 Added 37.83%
5,611 $175 Million
Q2 2024

Aug 06, 2024

SELL
$7.56 - $16.15 $216,699 - $462,923
-28,664 Reduced 87.56%
4,071 $63.2 Million
Q1 2024

May 09, 2024

BUY
$7.96 - $12.37 $182,769 - $284,027
22,961 Added 234.92%
32,735 $347 Million
Q4 2023

Feb 09, 2024

BUY
$4.9 - $12.86 $47,892 - $125,693
9,774 New
9,774 $117 Million

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.18B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Quest Partners LLC Portfolio

Follow Quest Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quest Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quest Partners LLC with notifications on news.